Irritable bowel syndrome is one of the most common gastrointestinal conditions in the world, affecting roughly 10 to 15 percent of the global population. For the people living with it, the impact is not just physical. IBS affects quality of life in ways that extend well beyond the bathroom: missed work, social anxiety, dietary restriction, and the exhausting daily calculus of what to eat and what to avoid.
Diet is central to managing IBS. It has been for decades. But a study published in 2025 in Neurogastroenterology and Motility is asking a question that could shift how clinicians and patients think about dietary management: is the Mediterranean diet, one of the most studied and broadly recommended eating patterns in the world, a viable alternative to the current gold standard?
The research comes from a team that includes Dr. William Chey, a leading voice in IBS research and a Coprata advisor, which makes the findings particularly relevant to follow.
The Current Standard: The Low-FODMAP Diet
For years, the low-FODMAP diet has been the most recommended dietary intervention for IBS and for good reason. The evidence supporting it is substantial. FODMAPs (fermentable oligosaccharides, disaccharides, monosaccharides, and polyols) are carbohydrates that ferment in the gut, which can trigger gas, bloating, and cramping in people with IBS.
The problem is that the diet is notoriously difficult to follow. It requires eliminating a long list of common foods, including garlic, onion, wheat, most legumes, many fruits, and dairy. After the restriction phase, a careful reintroduction process is needed to identify individual trigger foods. Done correctly, this process takes weeks of close attention and often requires guidance from a registered dietitian. The burden is significant, and adherence is a major challenge.
Finding an effective alternative is crucial for patients who struggle with the low-FODMAP diet or cannot sustain it long-term. This study aims to address that gap. If you're looking for support during the restriction process, it's worth knowing about Fodzyme, an enzyme supplement designed to help break down FODMAPs.
The Mediterranean Diet as a Gut Health Diet
The Mediterranean diet emphasizes whole foods like legumes, vegetables, fruits, olive oil, fish, and includes moderate amounts of dairy and lean protein. This way of eating is notably high in fiber and rich in beneficial plant compounds called polyphenols. It's associated with a wide range of positive health outcomes, such as a reduced risk of cardiovascular disease, improved metabolic health, and lower levels of systemic inflammation throughout the body.
From a gut health perspective, the Mediterranean diet has many features that make it particularly beneficial. The high fiber content, primarily from legumes and whole grains, acts as fuel for gut microbes, supporting a diverse microbial ecosystem and encouraging the production of short-chain fatty acids (SCFAs).
Additionally, the abundant polyphenols found in vegetables, fruits, and olive oil have well-documented anti-inflammatory effects that can soothe the gut lining. Because the diet is centered around whole, minimally processed foods, it naturally helps maintain a more favorable fecal pH, which is an indicator of a healthier overall gut environment.
With these established benefits in mind, the key question the study aimed to answer was whether these general gut health advantages could specifically translate into tangible symptom relief for individuals living with Irritable Bowel Syndrome (IBS).
What the Study Found
A pilot randomized controlled trial enrolled 20 participants with non-constipated IBS (diarrhea-predominant or mixed-type). They were assigned to either a Mediterranean or a low-FODMAP diet.
The main finding is that both diets provided symptom relief. This is significant because the Mediterranean diet, which is much easier to follow long-term than the low-FODMAP diet, showed meaningful benefits for these patients.
While the low-FODMAP diet offered greater symptom relief, the Mediterranean diet still competed on a meaningful level. The gap in effectiveness exists mainly because the low-FODMAP diet sets a very high bar for improvement.
As a small pilot study, these findings are promising but not definitive. The authors state that larger, real-world studies are needed before the Mediterranean diet can be routinely recommended for IBS management. This is early evidence, not a clinical directive.
To summarize the findings:
- The main finding was that both diets provided symptom relief. This is significant because the Mediterranean diet, which is easier to follow over the long term, showed meaningful benefits.
- While the low-FODMAP diet provided greater symptom relief, the Mediterranean diet remained a strong competitor. The effectiveness gap is primarily due to the low-FODMAP diet setting a very high standard for improvement.
- As a small pilot study, these findings are promising but not definitive.
- Suggesting that larger, real-world studies are needed before the Mediterranean diet can be routinely recommended for IBS management.
Why This Research Direction Matters
Finding a simple, effective diet for IBS could be a game-changer. The low-FODMAP diet is effective but requires significant commitment and professional guidance. In contrast, the Mediterranean diet is more accessible. Most people can start following it without a specialist, using widely available and familiar foods.
If larger studies confirm these initial findings, the dietary conversation around IBS could shift significantly. Instead of starting with a restrictive elimination diet, clinicians could recommend a positive eating pattern focused on what to include, not just what to remove.
For those currently managing IBS, the research offers a clear takeaway even now: a diet rich in whole grains, legumes, vegetables, olive oil, and fish is unlikely to worsen symptoms and may provide real relief. To see how your body responds to these changes, you can use tools like the MAT Kit (link) to gather objective data that complements your daily experience.
Reference
Prashant Singh, Gregory Dean, Sofia Iram, Westley Peng, Samuel W. Chey, Samara Rifkin, Christine Lothen-Kline, Jane Muir, Allen A. Lee, Shanti Eswaran, William D. Chey.
Efficacy of Mediterranean Diet vs. Low-FODMAP Diet in Patients With Nonconstipated Irritable Bowel Syndrome: A Pilot Randomized Controlled Trial. Neurogastroenterology and Motility. 2025;37(10):e70060. Open access.
Neurogastroenterology & Motility 37.10 (2025): e70060. OPEN ACCESS.
